475 related articles for article (PubMed ID: 31039731)
1. Effects of monoclonal antagonist antibodies on calcitonin gene-related peptide receptor function and trafficking.
Manoukian R; Sun H; Miller S; Shi D; Chan B; Xu C
J Headache Pain; 2019 Apr; 20(1):44. PubMed ID: 31039731
[TBL] [Abstract][Full Text] [Related]
2. CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine.
Maasumi K; Michael RL; Rapoport AM
Drugs; 2018 Jun; 78(9):913-928. PubMed ID: 29869205
[TBL] [Abstract][Full Text] [Related]
3. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
Tepper SJ
Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830
[TBL] [Abstract][Full Text] [Related]
4. A CGRP receptor antagonist peptide formulated for nasal administration to treat migraine.
von Mentzer B; Russo AF; Zhang Z; Kuburas A; Killoran PM; D'Aloisio V; Nizic L; Capel V; Kendall DA; Coxon CR; Hutcheon GA
J Pharm Pharmacol; 2020 Oct; 72(10):1352-1360. PubMed ID: 32588458
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic Characterization of AMG 334, a Potent and Selective Human Monoclonal Antibody against the Calcitonin Gene-Related Peptide Receptor.
Shi L; Lehto SG; Zhu DX; Sun H; Zhang J; Smith BP; Immke DC; Wild KD; Xu C
J Pharmacol Exp Ther; 2016 Jan; 356(1):223-31. PubMed ID: 26559125
[TBL] [Abstract][Full Text] [Related]
6. New Insights into the Regulation of CGRP-Family Receptors.
Gingell JJ; Hendrikse ER; Hay DL
Trends Pharmacol Sci; 2019 Jan; 40(1):71-83. PubMed ID: 30527443
[TBL] [Abstract][Full Text] [Related]
7. CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications.
Dodick DW
Cephalalgia; 2019 Mar; 39(3):445-458. PubMed ID: 30661365
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development.
Bigal ME; Walter S; Rapoport AM
Headache; 2013 Sep; 53(8):1230-44. PubMed ID: 23848260
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class.
Hargreaves R; Olesen J
Headache; 2019 Jun; 59(6):951-970. PubMed ID: 31020659
[TBL] [Abstract][Full Text] [Related]
10. Antigens and Antibodies in Disease With Specifics About CGRP Immunology.
Taylor FR
Headache; 2018 Nov; 58 Suppl 3():230-237. PubMed ID: 30187471
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterisation of erenumab, Aimovig, at two calcitonin gene-related peptide responsive receptors.
Garelja ML; Alexander TI; Bennie A; Nimick M; Petersen J; Walker CS; Hay DL
Br J Pharmacol; 2024 Jan; 181(1):142-161. PubMed ID: 37580864
[TBL] [Abstract][Full Text] [Related]
12. Targeting calcitonin gene-related peptide: a new era in migraine therapy.
Charles A; Pozo-Rosich P
Lancet; 2019 Nov; 394(10210):1765-1774. PubMed ID: 31668411
[TBL] [Abstract][Full Text] [Related]
13. CGRP, Amylin, Immunology, and Headache Medicine.
Taylor FR
Headache; 2019 Jan; 59(1):131-150. PubMed ID: 30390312
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin gene-related peptide - beyond migraine prophylaxis.
Olesen J; Ashina M
Nat Rev Neurol; 2019 Oct; 15(10):562-564. PubMed ID: 31488896
[No Abstract] [Full Text] [Related]
15. Therapeutic antibodies against CGRP or its receptor.
Bigal ME; Walter S; Rapoport AM
Br J Clin Pharmacol; 2015 Jun; 79(6):886-95. PubMed ID: 25614243
[TBL] [Abstract][Full Text] [Related]
16. Blocking the CGRP Pathway for Acute and Preventive Treatment of Migraine: The Evolution of Success.
Dubowchik GM; Conway CM; Xin AW
J Med Chem; 2020 Jul; 63(13):6600-6623. PubMed ID: 32058712
[TBL] [Abstract][Full Text] [Related]
17. How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice.
Tiseo C; Ornello R; Pistoia F; Sacco S
J Headache Pain; 2019 May; 20(1):49. PubMed ID: 31060490
[TBL] [Abstract][Full Text] [Related]
18. Calcitonin Gene-Related Protein (CGRP)-Targeted Treatments for Migraine Prevention.
Tepper DE
Headache; 2019 Mar; 59(3):477-480. PubMed ID: 30825209
[No Abstract] [Full Text] [Related]
19. Anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018.
Tepper SJ
Headache; 2018 Nov; 58 Suppl 3():276-290. PubMed ID: 30403405
[TBL] [Abstract][Full Text] [Related]
20. The CGRP Pathway in Migraine as a Viable Target for Therapies.
Edvinsson L
Headache; 2018 May; 58 Suppl 1():33-47. PubMed ID: 29697153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
